A detailed history of Redpoint Investment Management Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 47,295 shares of BMY stock, worth $2.45 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
47,295
Previous 55,741 15.15%
Holding current value
$2.45 Million
Previous $4.29 Million 21.67%
% of portfolio
0.49%
Previous 0.51%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$0.13 - $76.84 $1,097 - $648,990
-8,446 Reduced 15.15%
47,295 $3.36 Million
Q2 2022

Jul 08, 2022

BUY
$72.62 - $79.98 $46,331 - $51,027
638 Added 1.16%
55,741 $4.29 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $44,450 - $53,299
-723 Reduced 1.3%
55,103 $4.02 Million
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $47,462 - $55,330
-885 Reduced 1.56%
55,826 $3.48 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $161,060 - $188,661
-2,722 Reduced 4.58%
56,711 $3.36 Million
Q1 2021

Apr 13, 2021

BUY
$59.34 - $66.74 $18,098 - $20,355
305 Added 0.52%
59,433 $3.75 Million
Q4 2020

Jan 13, 2021

BUY
$57.74 - $65.43 $211,905 - $240,128
3,670 Added 6.62%
59,128 $3.67 Million
Q3 2020

Oct 09, 2020

SELL
$57.43 - $63.64 $4.44 Million - $4.92 Million
-77,356 Reduced 58.24%
55,458 $3.34 Million
Q2 2020

Jul 17, 2020

SELL
$54.82 - $64.09 $769,892 - $900,079
-14,044 Reduced 9.56%
132,814 $7.81 Million
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $424,699 - $617,186
-9,153 Reduced 5.87%
146,858 $8.19 Million
Q4 2019

Feb 25, 2020

BUY
$49.21 - $64.19 $1.99 Million - $2.59 Million
40,338 Added 34.87%
156,011 $10 Million
Q3 2019

Nov 26, 2019

BUY
$42.77 - $50.71 $35,071 - $41,582
820 Added 0.71%
115,673 $5.87 Million
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $724,137 - $800,738
-16,229 Reduced 12.38%
114,853 $5.21 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $80,719 - $96,248
1,789 Added 1.38%
131,082 $6.25 Million
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $88,987 - $115,394
-1,825 Reduced 1.39%
129,293 $6.72 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $165,956 - $187,185
-3,007 Reduced 2.24%
131,118 $8.14 Million
Q1 2018

Aug 09, 2018

SELL
$59.92 - $68.98 $349,513 - $402,360
-5,833 Reduced 4.17%
134,125 $8.48 Million
Q4 2017

Aug 09, 2018

BUY
$59.94 - $65.35 $8.39 Million - $9.15 Million
139,958
139,958 $8.58 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.